< Back to previous page
Researcher
Anne Uyttebroeck
- Disciplines:Morphological sciences, Oncology
Affiliations
- Pediatric Oncology (Division)
Member
From24 Jul 2018 → Today - Department of Oncology (Department)
Member
From1 Jan 2018 → 23 Jul 2018 - Woman and Child (Division)
Member
From1 Apr 2013 → 31 Dec 2017
Projects
1 - 8 of 8
- The neuro-oncological connectome: towards hub-driven analyses and neurocognition-sparing treatments for brain tumorsFrom1 Oct 2021 → 31 Jul 2022Funding: FWO junior postdoctoral fellowship
- Dynamic monitoring and risk assessment of chronic fatigue in survivors of childhood cancerFrom1 Apr 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- PanCare studies of the scale-up and implementation of the digital Survivorship Passport to improve people-centred care for childhood cancer survivorsFrom1 Mar 2021 → TodayFunding: H2020 - Health, demographic change and wellbeing
- Dynamic monitoring and risk assessment of chronic fatigue in survivors of childhood cancer.From1 Jan 2021 → 31 Dec 2022Funding: FWO Humanitarian research project Stand up against Cancer
- PanCareFollowUp: Novel, patient-centred survivorship care to improve care quality, effectiveness, cost-effectiveness and accessibility for survivors and caregiversFrom1 Jan 2019 → 31 Dec 2023Funding: H2020-EU.3.1. - SOCIETAL CHALLENGES - Health, demographic change and wellbeing
- Therapeutic delivery of exosome-microRNAs in pediatric rhabdomyosarcomaFrom5 Sep 2016 → 29 Nov 2021Funding: FWO Strategic Basic Research Grant
- Single cell molecular analysis of acute lymphoblastic leukemiaFrom1 Aug 2014 → 30 Sep 2018Funding: FWO fellowships
- From individual cancer genes to integrated cancer pathways in childhood cancer.From1 Jan 2011 → 31 Dec 2014Funding: FWO research project (including WEAVE projects)
Publications
11 - 20 of 193
- Differentiation between rebound thymic hyperplasia and thymic relapse after chemotherapy in pediatric Hodgkin lymphoma(2023)
Authors: Anne Uyttebroeck
- Effect of rituximab on immune status in children with mature B-cell non-Hodgkin lymphoma: a prespecified secondary analysis of the Inter-B-NHL Ritux 2010 trial(2023)
Authors: Anne Uyttebroeck
Pages: e445 - e457 - Perceived barriers and facilitators to health behaviors in European childhood cancer survivors: A qualitative PanCareFollowUp study(2023)
Authors: Anne Uyttebroeck
Pages: 12749 - 12764 - The prognostic value of IKZF1plus in B-cell progenitor acute lymphoblastic leukemia: Results from the EORTC 58951 trial(2023)
Authors: Anne Uyttebroeck
- Transcription factor NKX2-1 drives serine and glycine synthesis addiction in cancer(2023)
Authors: Elien Heylen, Paulien Verstraete, Linde Van Aerschot, Tom Venken, David Nittner, Anne Uyttebroeck, Heidi Segers, Diether Lambrechts, Jan Cools, Kim De Keersmaecker, et al.
Pages: 1862 - 1878 - Improving outcomes of childhood and young adult non-Hodgkin lymphoma: 25 years of research and collaboration within the framework of the European Intergroup for Childhood Non-Hodgkin Lymphoma(2023)
Authors: Anne Uyttebroeck
Pages: E213 - E224 - Associations between cancer-related distress and fatigue in childhood cancer survivors: A longitudinal study(2023)
Authors: Deveny Vanrusselt, Charlotte Sleurs, Sofie Prikken, Koen Raymaekers, Sabine Verschueren, Jurgen Lemiere, Koen Luyckx, Anne Uyttebroeck
Pages: 393 - 400 - Healthcare professionals' perceived barriers and facilitators of health behavior support provision: A qualitative study(2023)
Authors: Anne Uyttebroeck
Pages: 7414 - 7426 - t(1;7;22)(p13;q21;q13) is a novel 3-way variant of t(1;22)(p13;q13) neonatal acute megakaryoblastic leukemia: A case report(2023)
Authors: Julie Messiaen, Anne Uyttebroeck, Lucienne Michaux, Peter Vandenberghe, Nancy Boeckx, Sandra Jacobs
- Response-adapted omission of radiotherapy in children and adolescents with early-stage classical Hodgkin lymphoma and an adequate response to vincristine, etoposide, prednisone, and doxorubicin (EuroNet-PHL-C1): a titration study(2023)
Authors: Anne Uyttebroeck
Pages: 252 - 261